Sandra Donkervoort,Martijn van de Locht,Dario Ronchi,Janine Reunert,Catriona A. McLean,Maha Zaki,Rotem Orbach,Josine M. de Winter,Stefan Conijn,Daan Hoomoedt,Osorio Lopes Abath Neto,Francesca Magri,Angela N. Viaene,A. Reghan Foley,Svetlana Gorokhova,Véronique Bolduc,Ying Hu,Nicole Acquaye,Laura Napoli,Julien H. Park,Kalyan Immadisetty,Lee B. Miles,Mona Essawi,Salar McModie,Leonardo F. Ferreira,Simona Zanotti,Sarah B. Neuhaus,Livija Medne,Nagham ElBagoury,Kory R. Johnson,Yong Zhang,Nigel G. Laing,Mark R. Davis,Robert J. Bryson-Richardson,Darren T. Hwee,James J. Hartman,Fady I. Malik,Peter M. Kekenes-Huskey,Giacomo Pietro Comi,Wessam Sharaf-Eldin,Thorsten Marquardt,Gianina Ravenscroft,Carsten G. Bönnemann,Coen A. C. Ottenheijm

Abstract:Troponin I (TnI) regulates thin filament activation and muscle contraction. Two isoforms, TnI-fast ( TNNI2 ) and TnI-slow ( TNNI1 ), are predominantly expressed in fast- and slow-twitch myofibers, respectively. TNNI2 variants are a rare cause of arthrogryposis, whereas TNNI1 variants have not been conclusively established to cause skeletal myopathy. We identified recessive loss-of-function TNNI1 variants as well as dominant gain-of-function TNNI1 variants as a cause of muscle disease, each with distinct physiological consequences and disease mechanisms. We identified three families with biallelic TNNI1 variants (F1: p.R14H/c.190-9G>A, F2 and F3: homozygous p.R14C), resulting in loss of function, manifesting with early-onset progressive muscle weakness and rod formation on histology. We also identified two families with a dominantly acting heterozygous TNNI1 variant (F4: p.R174Q and F5: p.K176del), resulting in gain of function, manifesting with muscle cramping, myalgias, and rod formation in F5. In zebrafish, TnI proteins with either of the missense variants (p.R14H; p.R174Q) incorporated into thin filaments. Molecular dynamics simulations suggested that the loss-of-function p.R14H variant decouples TnI from TnC, which was supported by functional studies showing a reduced force response of sarcomeres to submaximal [Ca 2+ ] in patient myofibers. This contractile deficit could be reversed by a slow skeletal muscle troponin activator. In contrast, patient myofibers with the gain-of-function p.R174Q variant showed an increased force to submaximal [Ca 2+ ], which was reversed by the small-molecule drug mavacamten. Our findings demonstrated that TNNI1 variants can cause muscle disease with variant-specific pathomechanisms, manifesting as either a hypo- or a hypercontractile phenotype, suggesting rational therapeutic strategies for each mechanism.

A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C

Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy.

[Advances in the Molecular Pathogenesis of Hypertrophic Cardiomyopathy].

Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies

Pathogenic variants in TNNC2 cause congenital myopathy due to an impaired force response to calcium

A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy

Focus on cardiac troponin complex: From gene expression to cardiomyopathy

Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TNNI3 c.235C > T variant

Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients with Sporadic Dilated Cardiomyopathy

Early Divergence of the C-Terminal Variable Region of Troponin T Via a Pair of Mutually Exclusive Alternatively Spliced Exons Followed by a Selective Fixation in Vertebrate Heart

Identification of novel TTN gene variant in a patient exhibiting severe dilated cardiomyopathy co-occurring with acute fibrinoid organizing pneumonia

Hypertrophic Cardiomyopathy Mutations of Troponin Reveal Details of Striated Muscle Regulation

Pathogenic TNNI1 variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease

A Novel Arginine to Tryptophan (R144W) Mutation in Troponin T (cTnT) Gene in an Indian Multigenerational Family with Dilated Cardiomyopathy (FDCM)

A novel mutation in the TTN gene resulted in left ventricular noncompaction: a case report and literature review

TTN novel splice variant in familial dilated cardiomyopathy and splice variants review: a case report

[Novel Mutations of Cardiac Troponin T in Chinese Patients with Hypertrophic Cardiomyopathy].

TTN truncation variants produce sarcomere-integrating proteins of uncertain functional significance

Pathomechanisms of Monoallelic variants in TTN causing skeletal muscle disease

Missense variants in phospholamban and cardiac myosin binding protein identified in patients with a family history and clinical diagnosis of dilated cardiomyopathy

Integrated multi-omics approach revealed TTNtv c.13254T>G causing dilated cardiomyopathy in mice